The Technology Development Board (TDB) has penned an agreement with Peptris Technologies Pvt. Ltd. and the Foundation for Neglected Disease Research (FNDR), Bengaluru on 18th March.
- Under the agreement, the Board has sanctioned a grant of ₹75 Lakhs towards the project “ANAGRANINF – Development of a Novel Class of Antibiotics Against Gram-Negative Bacterial-Infections,” against the total project cost of ₹1.5 crores.
- The project’s primary objective is to develop a novel lead compound, particularly an antibiotic, adept at inhibiting the FabI enzyme and combatting critical gram-negative pathogens.
